✦ LIBER ✦

Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors

✍ Scribed by C Peduzzi; P Pierotti; G Venturi; L Romano; F Mazzotta; M Zazzi

Book ID: 117769516
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 75 KB
Volume: 25
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(01)00252-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Performance evaluation of an in-house hu

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon

✍ J. Fokam; R. Salpini; M. M. Santoro; V. Cento; R. D’Arrigo; C. Gori; C. F. Perno 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 541 KB

An ultrasensitive human immunodeficiency

An ultrasensitive human immunodeficiency virus type 1 protease radioimmuno rate assay with a potential for monitoring blood levels of protease inhibitors in acquired immunodeficiency disease syndrome patients

✍ David B. Evans; Anne F. Vosters; Thomas J. McQuade; Satish K. Sharma 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 558 KB

The angiotensin I-based peptide Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Glu-Glu-Ser yields angiotensin I (Ang I) and Leu-Glu-Glu-Ser upon hydrolysis by the human immunodeficiency virus type 1 (HIV-1) protease, but not by human renin. N-terminal sequencing of the reaction products showed that the

The use of drug resistance algorithms an

The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir–ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients

✍ Anne Maillard; Jean-Marc Chapplain; Olivier Tribut; Danièle Bentué-Ferrer; Pierr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 615 KB